Stock Screener App

Frei -

Installieren

2.77

25.91% 0.57

Relmada Therapeutics Inc (RLMD)

Überblick Nachrichten Preisverlauf Optionskette Financials Forum Prognose Aktiensplit

Finanzdaten der Relmada Therapeutics Inc-Aktie (RLMD)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	-	-	-	-	-
Operating Expenses	43.90% 10.22	18.22	19.08	23.01	18.82
Operating Income/Loss	43.90% -10.22	-18.22	-19.08	-23.01	-18.82
Nonoperating Income/Loss	46.15% 0.3549	0.659	0.4184	1.2829	1.0507
Income/Loss From Continuing Operations Before Tax	43.81% -9.8664	-17.56	-18.66	-21.73	-17.77
Income/Loss From Continuing Operations After Tax	43.81% -9.8664	-17.56	-18.66	-21.73	-17.77
Net Income/Loss	43.81% -9.8664	-17.56	-18.66	-21.73	-17.77
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	9.15% 33.19	30.41	0.00351	30.17	30.17
Diluted Average Shares	9.15% 33.19	30.41	0.00351	30.17	30.17
Basic Earnings Per Share	48.28% -0.30	-0.58	-0.62	-0.72	-0.59
Diluted Earnings Per Share	48.28% -0.30	-0.58	-0.62	-0.72	-0.59
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

RPRX

$37.84

1.45%

GMAB

$28.76

0.17%

INCY

$102.92

1.33%

BNTX

$104.83

0.84%

ONC

$309.19

0.86%

INSM

$182.77

1.86%

In Yahoo öffnen | In Google öffnen | In Finviz öffnen | In MarketWatch öffnen | Öffnen Sie in EDGAR | Offen in Reuters